Indian hospital major Apollo Group is all set to provide diabetes care to Malaysia through its health and lifestyle arm.

  With an estimated 3.2 million diabetics, Malaysia has one of the highest prevalence rates amongst adults worldwide for diabetes, with one in 6 affected by the lifestyle disease. Globally, diabetes and its complications caused 1.2 million deaths in 2014 - the highest mortality rate across the world. 54 per cent of these deaths are estimated to be in people under the age of 60.

  Apollo Health & Lifestyle Limited, a wholly owned subsidiary of Apollo Group and Ramsay Sime Darby Healthcare (Ramsay) have joined hands today to offer diabetes care to people of Malaysia, according to a  press release.

 

Prime Minister, Narendra Modi who was in Malaysia addressing the meeting of ASEAN had appealed for increased collaborations between India-Malaysia. He also reached out to the large population of Indian origin people for greater connect.

  Commenting on the partnership, Suneeta Reddy, Managing Director, Apollo Hospitals, and Chairperson, Apollo Health & Lifestyle Limited, said: “At Apollo, the program covers both diabetes treatment and also prevention and treatment of all its complications. Across India we deliver care to over 200,000 Diabetic patients through nearly 100 clinics (Apollo Clinics and Apollo Sugar Clinics)”.

Jacob Thomas, Chairman, Ramsay Sime Darby Health Care, said “This partnership with Apollo represents a significant milestone for our two leading care delivery organizations to come together to provide world class, evidence based care to people with diabetes across Malaysia. We will begin this collaboration with a state-of-the-art Centre of Excellence to be set up in Subang Jaya Medical Centre, our flagship hospital. This centre would be named Apollo Ramsay Sime Darby Health Care Centre for Obesity, Diabetes and Endocrinology.

  somasekhar.m@thehindu.co.in

comment COMMENT NOW